Marco Weibel
Chief Financial Officer
Switzerland
34 investmentsMarco Weibel is a Chief Financial Officer based in Switzerland. Marco Weibel has backed 34 companies, including Black Diamond Therapeutics, Blueprint Medicines and TRACON Pharmaceuticals. Investment focus areas include Health Care, Women Founded and Life Science.
Sign up to access email, LinkedIn & portfolio
Investment Focus
Portfolio Companies (34)
| Industry | Stage | Website | |||
|---|---|---|---|---|---|
| 1 | Black Diamond Therapeutics | — | — | — | — |
| 2 | Blueprint Medicines | — | — | — | — |
| 3 | TRACON Pharmaceuticals | — | — | — | — |
| 4 | Jounce Therapeutics | — | — | — | — |
| 5 | Peloton Therapeutics | — | — | — | — |
| 6 | Arvinas | — | — | — | — |
| 7 | Cullinan Oncology | — | — | — | — |
| 8 | Silverback Therapeutics | — | — | — | — |
| 9 | Sunesis Pharmaceuticals | — | — | — | — |
| 10 | MolecularMD | — | — | — | — |
| 11 | MOMA Therapeutics | — | — | — | — |
| 12 | Scorpion Therapeutics | — | — | — | — |
Showing 1–12 of 34
Page 1 of 3
Access Full Contact Information
Get Marco Weibel's email, LinkedIn, Twitter, full portfolio of investments, and export data to CSV.
Email
LinkedIn
Portfolio
No credit card required